Sudarshan Rajagopal
Experienced in Systemic Sclerosis (SSc)

Dr. Sudarshan Rajagopal

Cardiology
Private Diagnostic Clinic PLLC
40 Duke Medicine Cir, 
Durham,, NC 
Offers Telehealth

Experienced in Systemic Sclerosis (SSc)
Private Diagnostic Clinic PLLC
40 Duke Medicine Cir, 
Durham,, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

I take care of patients with pulmonary hypertension (PH). I also research signaling pathways that are altered in the development of PH in rodent models of the disease. PH covers a wide spectrum of diseases, from the rare pulmonary arterial hypertension (prevalence of 15 in one million) to complications of more common heart and lung disease. PH typically leads to complications through its effects on the heart, leading to heart failure. At the Duke Center for Pulmonary Vascular Disease we see a number of patients with PH and offer all available therapies, including continuous intravenous infusion, inhaled therapies, and surgical options.

Dr. Rajagopal is rated as an Experienced provider by MediFind in the treatment of Systemic Sclerosis (SSc). His top areas of expertise are Pulmonary Hypertension, Hypertension, Pulmonary Veno-Occlusive Disease, Embolectomy, and Angioplasty.

His clinical research consists of co-authoring 114 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Cardiology
Licenses
Internal Medicine in NC
Board Certifications
American Board Of Internal Med, Internal Medicine
American Board Of Internal Med, Cardiovascular Disease
Fellowships
Cardiology Research Fellow, Duke University Medical Center, Cardiology Clinical Fellow, Duke University Medical Center
Hospital Affiliations
Duke University Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Absolute Total Care South Carolina
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Ambetter
  • EPO
  • HMO
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
FirstCarolinaCare
  • HMO
  • MEDICARE MAPD
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Piedmont
  • HMO
  • POS
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Private Diagnostic Clinic PLLC
40 Duke Medicine Cir, Durham,, NC 27710
Call: 919-684-8111
Other Locations
Duke Children's Hospital & Health Center
1926 Good Hope Rd, Enola,, PA 17025
Call: 919-684-8111

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


7 Clinical Trials

A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: June 04, 2025
Intervention Type: Drug
Study Drug: Rodatristat Ethyl
Study Phase: Phase 2
Assessing Response to Inhaled Prostacyclin With Hyperpolarized Xe MRI
Assessing Response to Inhaled Prostacyclin With Hyperpolarized Xe MRI
Enrollment Status: Completed
Publish Date: October 18, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
Non-Invasive Diagnosis of Pulmonary Vascular Disease Using Inhaled 129Xe Magnetic Resonance Imaging
Non-Invasive Diagnosis of Pulmonary Vascular Disease Using Inhaled 129Xe Magnetic Resonance Imaging
Enrollment Status: Completed
Publish Date: February 22, 2022
Intervention Type: Device, Drug
Study Phase: Phase 2
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2a, Double-Blind, Placebo-Controlled Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of RVT-1201 in Patients With Pulmonary Arterial Hypertension
A Phase 2a, Double-Blind, Placebo-Controlled Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of RVT-1201 in Patients With Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: March 09, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

114 Total Publications

CXCR1 and CXCR2 display receptor bias for shared chemokine agonists.
CXCR1 and CXCR2 display receptor bias for shared chemokine agonists.
Journal: bioRxiv : the preprint server for biology
Published: November 19, 2025
View All 114 Publications
Similar Doctors
Terry Fortin
Advanced in Systemic Sclerosis (SSc)
Dr. Terry Fortin
Cardiology
Advanced in Systemic Sclerosis (SSc)
Dr. Terry Fortin
Cardiology

Private Diagnostic Clinic PLLC

40 Duke Medicine Cir, 
Durham,, NC 
 (0.1 miles away)
919-668-7630
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Terry Fortin is a Cardiologist in Durham,, North Carolina. Dr. Fortin is rated as a Distinguished provider by MediFind in the treatment of Systemic Sclerosis (SSc). Her top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Cardiogenic Shock, and Eisenmenger Syndrome.

David C. Ishizawar
Experienced in Systemic Sclerosis (SSc)
Dr. David C. Ishizawar
Advanced Heart Failure and Transplant Cardiology | Cardiology
Experienced in Systemic Sclerosis (SSc)
Dr. David C. Ishizawar
Advanced Heart Failure and Transplant Cardiology | Cardiology

Rex Hospital Inc

2800 Blue Ridge Rd, Suite 204, 
Raleigh, NC 
 (18.3 miles away)
919-784-3200
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

David Ishizawar is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist in Raleigh, North Carolina. Dr. Ishizawar is rated as a Distinguished provider by MediFind in the treatment of Systemic Sclerosis (SSc). His top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Heart Failure, and Heart Failure with Preserved Ejection Fraction (HFpEF). Dr. Ishizawar is currently accepting new patients.

Daniel R. Bensimhon
Experienced in Systemic Sclerosis (SSc)
Dr. Daniel R. Bensimhon
Advanced Heart Failure and Transplant Cardiology | Cardiology
Experienced in Systemic Sclerosis (SSc)
Dr. Daniel R. Bensimhon
Advanced Heart Failure and Transplant Cardiology | Cardiology

The Moses H Cone Memorial Hospital Operating Corporation

1126 N Church St, Suite 300, 
Greensboro, NC 
 (47.7 miles away)
336-938-0800
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Daniel Bensimhon is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist in Greensboro, North Carolina. Dr. Bensimhon is rated as a Distinguished provider by MediFind in the treatment of Systemic Sclerosis (SSc). His top areas of expertise are Heart Failure, Pulmonary Edema, Heart Failure with Preserved Ejection Fraction (HFpEF), Hypertensive Heart Disease, and Endoscopy. Dr. Bensimhon is currently accepting new patients.

VIEW MORE SYSTEMIC SCLEROSIS (SSC) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rajagopal's expertise for a condition
ConditionClose
  • Elite
  • Pulmonary Hypertension
    Dr. Rajagopal is
    Elite
    . Learn about Pulmonary Hypertension.
    See more Pulmonary Hypertension experts
  • Distinguished
  • Hypertension
    Dr. Rajagopal is
    Distinguished
    . Learn about Hypertension.
    See more Hypertension experts
  • Pulmonary Veno-Occlusive Disease
    Dr. Rajagopal is
    Distinguished
    . Learn about Pulmonary Veno-Occlusive Disease.
    See more Pulmonary Veno-Occlusive Disease experts
  • Advanced
  • Heart Failure
    Dr. Rajagopal is
    Advanced
    . Learn about Heart Failure.
    See more Heart Failure experts
  • Pulmonary Embolism
    Dr. Rajagopal is
    Advanced
    . Learn about Pulmonary Embolism.
    See more Pulmonary Embolism experts
  • Experienced
  • Angioplasty
    Dr. Rajagopal is
    Experienced
    . Learn about Angioplasty.
    See more Angioplasty experts
  • Arterial Embolism
    Dr. Rajagopal is
    Experienced
    . Learn about Arterial Embolism.
    See more Arterial Embolism experts
  • Atrial Fibrillation
    Dr. Rajagopal is
    Experienced
    . Learn about Atrial Fibrillation.
    See more Atrial Fibrillation experts
  • Cor Pulmonale
    Dr. Rajagopal is
    Experienced
    . Learn about Cor Pulmonale.
    See more Cor Pulmonale experts
  • Embolectomy
    Dr. Rajagopal is
    Experienced
    . Learn about Embolectomy.
    See more Embolectomy experts
  • Heart Failure with Preserved Ejection Fraction (HFpEF)
    Dr. Rajagopal is
    Experienced
    . Learn about Heart Failure with Preserved Ejection Fraction (HFpEF).
    See more Heart Failure with Preserved Ejection Fraction (HFpEF) experts
View All 14 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.